Related Experiment Video
Updated: Sep 21, 2025
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
264
Management of Hypertension with Female Sexual Dysfunction
1Bioscience Department, Rocky Vista University College of Osteopathic Medicine, Ivins, UT 84738, USA.
Medicina (Kaunas, Lithuania)
|May 28, 2022
Summary
Female sexual dysfunction (FSD) is more common in women with hypertension. Beta-blockers may worsen FSD, while angiotensin receptor blockers (ARBs) show benefits. Managing blood pressure is crucial for treating FSD in hypertensive women.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Female sexual dysfunction (FSD) in hypertensive women is understudied compared to men.
- The effects of antihypertensive medications on female sexual function require clarification.
Purpose of the Study:
- To review the impact of hypertension and its treatments on female sexual function.
- To identify antihypertensive agents affecting FSD and recommend management strategies.
Main Methods:
- Systematic review of randomized double-blind clinical trials and cross-sectional studies.
- Analysis of studies published between 1991 and 2021.
Main Results:
- Hypertensive women exhibit higher rates of FSD compared to normotensive women.
- Beta-blockers are associated with negative effects on female sexual function.
- Angiotensin receptor blockers (ARBs) demonstrate a beneficial impact on female sexual function.
Conclusions:
- Controlling blood pressure is paramount for treating FSD in hypertensive individuals.
- ARBs are preferred for managing FSD in hypertensive women.
- Specific treatments like flibanserin, bremelanotide, ospemifene, and hormone supplements may be considered based on menopausal status.
Related Concept Videos
01:23Hypertension V: Nursing Management
52
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
52
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
62
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
62
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
256
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
256
01:23Antihypertensive Drugs: Vasodilators
667
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
667
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
528
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
528
01:30Heart Failure V: Medical Management
36
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36